Diabetes MellitusNCT01983007
Effect of Physical Exercise on Endothelial Function in Patients With Type 2 Diabetes Mellitus
A study testing High-intensity exercise and Low-intensity exercise in people with Diabetes Mellitus, run by Universidade Federal do Ceara at 1 site in Brazil.
Trial summary
Endothelial dysfunction precedes the development of cardiovascular disease and it is common in patients with diabetes mellitus. The aim of this study is to identify the effect of two different physical training programs, using ultrasound techniques, on the endothelial function of patients with type 2 DM. Read more about this study
- Who is it for?
- Ages 40 to 65 years
- Conditions the study is for
- Diabetes Mellitus
- What is being tested?
- High-intensity exercise and Low-intensity exercise
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 31 participants
- Where
- 1 siteBrazil
- Study dates
- Jan 2012to Dec 2012
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Subjects with type 2 DM, of both genders, aged between 40 and 65 years, without coronary artery disease, characterized by a negative maximum exercise test
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
Brazil1 site
Prevention and Cardiovascular Rehabilitation Unit Unicardio, in Hospital Santa Catarina
Blumenau, Santa Catarina
About this study
Endothelial dysfunction precedes the development of cardiovascular disease and it is common in patients with diabetes mellitus. The aim of this study is to identify the effect of two different physical training programs, using ultrasound techniques, on the endothelial function of patients with type 2 DM.
Read the detailed description
Subjects Subjects with type 2 DM, of both genders, aged between 40 and 65 years, without coronary artery disease, characterized by a negative maximum exercise test, will be studied. This study will be carried out at the Prevention and Cardiovascular Rehabilitation Unit Unicardio, in Hospital Santa Catarina, in the city of Blumenau, State of Santa Catarina, South of Brazil. The patients will be invited to participate in the study as they are treated at the clinic during regular medical consultations, with approximately 235 patients per month. After that, patient randomization will be carried out, by dividing the patients in the groups: intervention (a group undergoing high-intensity exercise and another one undergoing low-intensity exercise) and control group (patients not submitted to the physical exercise program, but went to the health care center to undergo blood pressure and heart rate measurement).
The following exclusion criteria will be used: subjects in whom, for reasons related to clinical screening, it is not possible to withdrawn medications with known endothelial function effect, such as angiotensin-converting enzyme inhibitors, calcium channel blockers, nitrates, beta-blockers, anti-oxidizers, hormonal replacement therapy, insulin; subjects with altered maximum exercise test (positive); cigarette smoking history in the last 12 months; participation in a physical exercise program in the last 12 months; chronic obstructive pulmonary disease; high blood pressure levels (systolic blood pressure > 180mmHg and diastolic blood pressure > 110mmHg); osteoporosis and diabetic neuropathy.
The study protocol is in accordance with the Declaration of Helsinki. All participants will be informed of the objectives of the study and possible risks and discomforts involved with their participation in the experiments, and will be included only after signing the informed consent term. The study protocol was approved by the Ethics Committee of Hospital Santa Catarina (Blumenau, Santa Catarina, Brazil).
Study Protocol All study subjects will undergo an initial clinical examination performed by a cardiologist. Before and after 6 weeks of intervention, the patients will undergo the maximum exercise test, physical examination and endothelial function evaluation. The participants will be submitted to a program of physical exercise in the Prevention and Cardiovascular Rehabilitation Unit Unicardio of Hospital Santa Catarina, in Blumenau, Brazil. After the maximum exercise test is limited by fatigue, the participants will be referred, based on their individual exercise prescription and randomized to a low (50 to 60% of maximum heart rate) or high intensity (75 to 85% of maximum heart rate) exercise program. During the study period, the patients should maintain the same doses of medications.
All patients will undergo a non-invasive evaluation of endothelial function, performed at Clínica Uniangio, in the city of Blumenau, Brazil. Two investigators will perform all the tests, while blinded to the group the patients were randomized to. All patients will undergo an 8-12 hour period of food and water deprivation. The individuals will be placed in the supine position, with the arms placed along the body in a comfortable position to obtain image of the brachial artery, above the antecubital fossa, in the longitudinal plane.
An ultrasonic sound wave equipment will be used (Acuson, Model 128XP System, Mountain View, California, USA), with vascular software for two-dimensional images (2D), color Doppler with an internal electrocardiogram (ECG) monitor and a high-frequency vascular transducer (Acuson, Model L7 7,5-10 MHz, Mountain View, California, USA). After positioned, a segment with anterior and posterior interfaces with the arterial wall will be selected for 2D images. Arterial diameter values will be recorded in super-VHS for subsequent analysis.
- Conditions
- Diabetes Mellitus
- Being tested
- High-intensity exercise, Low-intensity exercise
- Keywords
- Diabetes Mellitus.
- Medical subject headings
- Diabetes Mellitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
High-intensity exerciseProcedure or surgery
Performance of high-intensity exercise
Low-intensity exerciseProcedure or surgery
Performance of low-intensity exercise
| Study group | Role | What they receive |
|---|---|---|
| high-intensity exercise group | Experimental | Patients undergoing high-intensity exercise group. Intervention: high-intensity exercise. Receives: Procedure: High-intensity exercise |
| low-intensity exercise group | Experimental | Patients undergoing low-intensity exercise group Intervention: low-intensity exercise Receives: Procedure: Low-intensity exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Arterial dilation
Measured: 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Nov 2013 (estimated)
- Study startJan 2012
- Primary completionDec 2012
- Study completionDec 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diabetes MellitusStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Double blind
- Who is masked
- Care provider, Investigator
- Enrolment
- 31 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidade Federal do Ceara
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Geraldo Bezerra da Silva Junior, Universidade Federal do Ceara
- Investigators
- Carlos Alberto Silva, PhD, Principal investigator, Universidade Federal do Ceara
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01983007
- Sponsor's protocol ID
- 14343
- Status last verified
- Mar 2014
- First submitted
- 6 Nov 2013
- Last updated
- 21 Mar 2014
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 21 Mar 2014. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Physical Exercise on Endothelial Function in Patients With Type 2 Diabetes Mellitus
- ClinicalTrials.gov ID
- NCT01983007
- Acronym / sponsor ID
- 14343
- Conditions
- Diabetes Mellitus
- Keywords
- Diabetes Mellitus.
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 31 participants (actual)
- Lead sponsor
- Universidade Federal do CearaUniversity, hospital or other
- Study start
- Jan 2012
- Primary completion
- Dec 2012 (actual)
- Study completion
- Dec 2012 (actual)
- First posted
- 13 Nov 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Endothelial dysfunction precedes the development of cardiovascular disease and it is common in patients with diabetes mellitus. The aim of this study is to identify the effect of two different physical training programs, using ultrasound techniques, on the endothelial function of patients with type 2 DM.
Detailed description
Subjects Subjects with type 2 DM, of both genders, aged between 40 and 65 years, without coronary artery disease, characterized by a negative maximum exercise test, will be studied. This study will be carried out at the Prevention and Cardiovascular Rehabilitation Unit Unicardio, in Hospital Santa Catarina, in the city of Blumenau, State of Santa Catarina, South of Brazil. The patients will be invited to participate in the study as they are treated at the clinic during regular medical consultations, with approximately 235 patients per month. After that, patient randomization will be carried out, by dividing the patients in the groups: intervention (a group undergoing high-intensity exercise and another one undergoing low-intensity exercise) and control group (patients not submitted to the physical exercise program, but went to the health care center to undergo blood pressure and heart rate measurement).
The following exclusion criteria will be used: subjects in whom, for reasons related to clinical screening, it is not possible to withdrawn medications with known endothelial function effect, such as angiotensin-converting enzyme inhibitors, calcium channel blockers, nitrates, beta-blockers, anti-oxidizers, hormonal replacement therapy, insulin; subjects with altered maximum exercise test (positive); cigarette smoking history in the last 12 months; participation in a physical exercise program in the last 12 months; chronic obstructive pulmonary disease; high blood pressure levels (systolic blood pressure > 180mmHg and diastolic blood pressure > 110mmHg); osteoporosis and diabetic neuropathy.
The study protocol is in accordance with the Declaration of Helsinki. All participants will be informed of the objectives of the study and possible risks and discomforts involved with their participation in the experiments, and will be included only after signing the informed consent term. The study protocol was approved by the Ethics Committee of Hospital Santa Catarina (Blumenau, Santa Catarina, Brazil).
Study Protocol All study subjects will undergo an initial clinical examination performed by a cardiologist. Before and after 6 weeks of intervention, the patients will undergo the maximum exercise test, physical examination and endothelial function evaluation. The participants will be submitted to a program of physical exercise in the Prevention and Cardiovascular Rehabilitation Unit Unicardio of Hospital Santa Catarina, in Blumenau, Brazil. After the maximum exercise test is limited by fatigue, the participants will be referred, based on their individual exercise prescription and randomized to a low (50 to 60% of maximum heart rate) or high intensity (75 to 85% of maximum heart rate) exercise program. During the study period, the patients should maintain the same doses of medications.
All patients will undergo a non-invasive evaluation of endothelial function, performed at Clínica Uniangio, in the city of Blumenau, Brazil. Two investigators will perform all the tests, while blinded to the group the patients were randomized to. All patients will undergo an 8-12 hour period of food and water deprivation. The individuals will be placed in the supine position, with the arms placed along the body in a comfortable position to obtain image of the brachial artery, above the antecubital fossa, in the longitudinal plane.
An ultrasonic sound wave equipment will be used (Acuson, Model 128XP System, Mountain View, California, USA), with vascular software for two-dimensional images (2D), color Doppler with an internal electrocardiogram (ECG) monitor and a high-frequency vascular transducer (Acuson, Model L7 7,5-10 MHz, Mountain View, California, USA). After positioned, a segment with anterior and posterior interfaces with the arterial wall will be selected for 2D images. Arterial diameter values will be recorded in super-VHS for subsequent analysis.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Double blind (care provider, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| high-intensity exercise group | Experimental | Procedure: High-intensity exercisePatients undergoing high-intensity exercise group. Intervention: high-intensity exercise. |
| low-intensity exercise group | Experimental | Procedure: Low-intensity exercisePatients undergoing low-intensity exercise group Intervention: low-intensity exercise |
Who may qualify
- Ages
- 40 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Subjects with type 2 DM, of both genders, aged between 40 and 65 years, without coronary artery disease, characterized by a negative maximum exercise test
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| High-intensity exercisePerformance of high-intensity exercise | Procedure or surgery | high-intensity exercise group |
| Low-intensity exercisePerformance of low-intensity exercise | Procedure or surgery | low-intensity exercise group |
Primary outcome
Arterial dilation
Time frame: 6 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Mar 2014.
Related trials for Diabetes Mellitus
RecruitingObservational study
Genetics of Type 2 Diabetes in West Africans
Hypertension, Diabetes
Not yet recruiting
A Study to Lower Blood Pressure One Year After Childbirth in Women Who Had Preeclampsia
Adverse Pregnancy Outcomes, Cardiovascular Diseases
Not yet recruitingPhase 3
A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin
Diabetes Mellitus, Type 2
Not yet recruiting
Different Aerobic-to-Resistance Training Ratios in Adults Aged 50 Years and Older With Prediabetes
Prediabetes
Active, not recruiting
Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes
Type 1 Diabetes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carlos Alberto Silva, PhD principal investigator
Universidade Federal do Ceara
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing High-intensity exercise and Low-intensity exercise in people with Diabetes Mellitus, run by Universidade Federal do Ceara at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Mar 2014. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Arterial dilation (time frame: 6 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2014.